Corundum Open Innovation
Status
ACTIVE
Global HQ
Herzliya, Israel
Countries of investment
- Israel
- Japan
Investment stages
- Series B
- Series C
Industries
- Fintech
- Robotics
- Digital Health
- AI
- Cloud Computing
- Mobility
- Cybersecurity
About
Corundum Open Innovation is a dynamic venture capital firm established in 2015, operating at the intersection of Israeli innovation and Japanese corporate expertise. With robust backing from leading Japanese corporations, Corundum strategically invests in high-tech companies and funds across Israel, harnessing the region's cutting-edge advancements. Our dedicated teams in both Japan and Israel facilitate meaningful partnerships and provide unparalleled access to innovative technologies, fostering growth and collaboration between these two vibrant ecosystems. Through our commitment to open innovation, we aim to drive transformative solutions that benefit both our portfolio companies and investors alike.
Corundum Open Innovation is a dynamic venture capital firm established in 2015, operating at the intersection of Israeli innovation and Japanese corporate expertise. With robust backing from leading Japanese corporations, Corundum strategically invests in high-tech companies and funds across Israel, harnessing the region's cutting-edge advancements. Our dedicated teams in both Japan and Israel facilitate meaningful partnerships and provide unparalleled access to innovative technologies, fostering growth and collaboration between these two vibrant ecosystems. Through our commitment to open innovation, we aim to drive transformative solutions that benefit both our portfolio companies and investors alike.
Investment Thesis
Corundum Open Innovation invests in startups that drive open innovation in industries like healthcare, AI, and digital transformation, with a focus on leveraging new technologies to create scalable solutions.
Manager's Experience
Backed by over a decade of investment experience, the fund manager has successfully navigated multiple sectors, including technology, healthcare, and consumer goods. Active across North America and Europe, they have executed more than 25 deals, demonstrating a strong ability to identify high-growth opportunities. Their strategic style emphasizes a data-driven approach, allowing for informed decision-making throughout various investment stages. Notable exits include several high-profile acquisitions that highlight their expertise in optimizing portfolio performance.